Dublin, Oct. 22, 2018 (GLOBE NEWSWIRE) -- The "Global Viral Vector Manufacturing Markets and Technologies Through 2022" report has been added to ResearchAndMarkets.com's offering.

The scope of this report is broad and covers various types of products available, ongoing research and development in the viral vector vaccine manufacturing market, and potential application sectors across various industries. The viral vector vaccine manufacturing market is broken down by types, application and diseases. Revenue forecasts from 2017 to 2022 are given for each product type, application and diseases with estimated valued derived from the revenue of manufacturers' total revenues.

The report also includes a discussion of the major players across each regional viral vector vaccine manufacturing market. Further, it explains the major drivers and regional dynamics of the global viral vector vaccine manufacturing market and current trends within the industry.

The report concludes with a special focus on the vendor landscape and includes detailed profiles of the major vendors in the global viral vector vaccine manufacturing market.

The Report Includes:

• 145 data tables and 57 additional tables
• A detailed overview and industry analysis of the global viral vector manufacturing market
• Analyses of global market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
• Information on major drivers and regional dynamics of the global viral vector vaccine manufacturing market and current trends within the industry
• Insight into pipeline products that are manufactured using viral vector tools and technology, and a relevant patent analysis
• Company profiles of major market players including Advanced Bioscience Laboratories Inc., Boehringer Ingelheim Gmbh, Brammer Bio Llc, Creative Biogene, GE Healthcare, Pfizer Inc., Sanofi SA, and Spark Therapeutics Inc.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

• Evolution and Transition
• Market Potential
• WHO
• U.S.
• European Union
• Australia
• Japan
• India
• China
• Market Segmentation
• Segmentation by Type
• Segmentation by Application
• Segmentation by Disease
• Regional Analysis

Chapter 4 Market Drivers

• Rising Number of Clinical Trials in Viral Vectors
• Growing Number of Gene Therapy Candidates
• Surging Investment in Gene-Therapy-Based R&D Activities
• Increasing Prevalence of Genetic Disorders and Chronic Diseases

Chapter 5 Market Breakdown by Type

• Overview
• Adenoviral Vectors
• Retroviral Vectors
• Lentiviral Vectors
• Adeno-associated Viral Vectors
• Cytomegalovirus
• Pox Virus
• Other Viral Vectors

Chapter 6 Market Breakdown by Disease Application

• Overview
• Human Disease Applications
• Overview
• Hepatitis
• Cancer
• Influenza
• HIV
• Tuberculosis
• Malaria
• Others
• Veterinary Disease Applications
• Avian Influenza
• Marek's Disease
• Infectious Bronchitis
• PPR Disease
• Others (Rabies, FMD, Swine Influenza, Equine Influenza, Newcastle Disease, etc.)

Chapter 7 Market Breakdown by Application Type

• Overview
• Multivalent Viral Vector Vaccines
• Multipathogen Viral Vector Vaccines

Chapter 8 Market Breakdown by Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• U.K.
• France
• Spain
• Italy
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia-Pacific
• Rest of the World (ROW)
• Latin America
• Middle East and Africa

Chapter 9 Viral Vector Manufacturing Industry Structure

• Viral Vector Manufacturing Supply Chain
• Common Steps Followed in Small-Scale Manufacturing of Adenovirus
• Step 1: Cell Lysis and Genomic DNA Breakdown
• Step 2: Clarification
• Step 3: Concentration
• Steps 4 and 5: Anion Exchange and Gel Filtration
• Step 6: Membrane Filtration
• Companies Involved in Developing Lentiviral Vector Candidates
• Companies Involved in Developing Adeno-associated Vector (AAV) Candidates
• Manufacturer Purchasing Criteria
• Innovation within the Viral Vector Vaccine Manufacturing Industry
• Competitive Landscape
• Expansions
• Collaborations
• Investments
• Acquisitions

Chapter 10 Patent Analysis

• U.S. Patent Analysis
• European Patent Analysis
• Japanese Patent Analysis

Chapter 11 Company Profiles

• Advanced Bioscience Laboratories, Inc.
• Advanced Biotherapeutics Consulting
• Applied Viromics
• Batavia Biosciences
• Benitec Biopharma
• Biogen Idec (Now Biogen, Inc.)
• Biovian
• Boehringer Ingelheim Gmbh
• Brammer Bio
• Cell And Gene Therapy Catapult
• Ceva Corporate
• Cobra Biologics (Subsidiary Of Recip Ab)
• Creative Biogene
• GE Healthcare
• Genedetect
• Genvec Inc. (Subsidiary Of Intrexon Corp.)
• ID Pharma Co. Ltd.
• Janssen Pharmaceutical Companies Of Johnson & Johnson
• Lonza
• Merck Millipore
• Miltenyi Biotec
• Molmed Spa
• Paragon Bioservices Inc.
• Pfizer Inc.
• Sanofi
• Sementis
• Spark Therapeutics Inc.
• Synpromics
• Valneva
• Vector Biolabs
• Vigene Biosciences Inc.
• Virovek
  

For more information about this report visit https://www.researchandmarkets.com/research/gjw7cc/global_viral?w=12

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

                  CONTACT: ResearchAndMarkets.com
                           Laura Wood, Senior Press Manager
                           press@researchandmarkets.com
                           For E.S.T Office Hours Call 1-917-300-0470
                           For U.S./CAN Toll Free Call 1-800-526-8630
                           For GMT Office Hours Call +353-1-416-8900
                  Related Topics: Genomics